Goldman Sachs’s Direxion Daily Biotech Top 5 Bull 2X ETF TBXU Stock Holding History

Goldman Sachs’s Portfolio TBXU Stock Details TBXU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$784K	Hold	25,000	–	–	﹤0.01%	5269
2025 Q4	$777K	Buy	+25,000	New	+$747K	﹤0.01%	5304

Other funds holding TBXU

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Goldman Sachs's TBXU Position: Q1 2026 in Review

Goldman Sachs held its Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) position steady in Q1 2026 at 25,000 shares worth $784K. The position accounts for ﹤0.01% of the portfolio, ranked #5269.

Goldman Sachs first reported a position in TBXU in Q4 2025 and has held it in 2 quarters since. 3 funds tracked by Wall St. Rank hold TBXU as of Q1 2026.

Goldman Sachs held 25,000 shares of Direxion Daily Biotech Top 5 Bull 2X ETF worth $784K as of Q1 2026.
Goldman Sachs left its Direxion Daily Biotech Top 5 Bull 2X ETF share count unchanged in Q1 2026.
Direxion Daily Biotech Top 5 Bull 2X ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5269 holding.
Goldman Sachs first reported a position in Direxion Daily Biotech Top 5 Bull 2X ETF in Q4 2025 and has held it in 2 quarters since.
3 funds tracked by Wall St. Rank held Direxion Daily Biotech Top 5 Bull 2X ETF as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.